Robert Mairs
Robert Mairs
Institute of Cancer Sciences, Glasgow University
Verified email at - Homepage
Cited by
Cited by
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides
M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ...
Journal of nuclear medicine 47 (6), 1007-1015, 2006
Feasibility of Dosimetry-Based High-Dose 131I-Meta-Iodobenzylguanidine with Topotecan as a Radiosensitizer in Children with Metastatic Neuroblastoma
MN Gaze, YC Chang, GD Flux, RJ Mairs, FH Saran, ST Meller
Cancer biotherapy & radiopharmaceuticals 20 (2), 195-199, 2005
The effect of cytotoxic therapy on saliva and oral flora
BE Main, KC Calman, MM Ferguson, SB Kaye, TW MacFarlane, RJ Mairs, ...
Oral Surgery, Oral Medicine, Oral Pathology 58 (5), 545-548, 1984
Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine
M Boyd, SH Cunningham, MM Brown, RJ Mairs, TE Wheldon
Gene therapy 6 (6), 1147-1152, 1999
The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells
C Rae, M Tesson, JW Babich, M Boyd, A Sorensen, RJ Mairs
Journal of Nuclear Medicine 54 (6), 953-960, 2013
Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models
S Carlin, SH Cunningham, M Boyd, AG McCluskey, RJ Mairs
Cancer gene therapy 7 (12), 1529-1536, 2000
Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution
JA Barrett, JL Joyal, SM Hillier, KP Maresca, FJ Femia, JF Kronauge, ...
Cancer biotherapy & radiopharmaceuticals 25 (3), 299-308, 2010
An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effects
M Boyd, RJ Mairs, WN Keith, SC Ross, P Welsh, G Akabani, J Owens, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[131I] iodobenzylguanidine by neuroblastoma tumors
S Carlin, RJ Mairs, AG McCluskey, DA Tweddle, A Sprigg, C Estlin, ...
Clinical cancer research 9 (9), 3338-3344, 2003
Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro
RJ Mairs, K Hughes, S Fitzsimmons, KM Prise, A Livingstone, L Wilson, ...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 626 (1-2 …, 2007
Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction
RJ Mairs, A Livingstone, MN Gaze, TE Wheldon, A Barrett
British journal of cancer 70 (1), 97-101, 1994
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes
MN Gaze, RJ Mairs, SM Boyack, TE Wheldon, A Barrett
British journal of cancer 66 (6), 1048-1052, 1992
Sodium-iodide symporter (NIS)-mediated accumulation of [211At] astatide in NIS-transfected human cancer cells
S Carlin, RJ Mairs, P Welsh, MR Zalutsky
Nuclear medicine and biology 29 (7), 729-739, 2002
No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation
RJ Mairs, SH Cunningham, J Russell, A Armour, J Owens, K McKellar, ...
Journal of Nuclear Medicine 36 (6), 1088-1095, 1995
Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma131I-Labeled Benzamide for Targeted Melanoma Radiotherapy
JL Joyal, JA Barrett, JC Marquis, J Chen, SM Hillier, KP Maresca, M Boyd, ...
Cancer research 70 (10), 4045-4053, 2010
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions
SH Cunningham, RJ Mairs, TE Wheldon, PC Welsh, G Vaidyanathan, ...
British journal of cancer 77 (12), 2061-2068, 1998
Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy
M Boyd, SC Mairs, K Stevenson, A Livingstone, AM Clark, SC Ross, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2002
Localized irradiation of cell membrane by auger electrons is cytotoxic through oxidative stress-mediated nontargeted effects
S Paillas, R Ladjohounlou, C Lozza, A Pichard, V Boudousq, M Jarlier, ...
Antioxidants & redox signaling 25 (8), 467-484, 2016
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
DL Nile, C Rae, IJ Hyndman, MN Gaze, RJ Mairs
BMC cancer 16 (1), 1-13, 2016
[131I] meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter
AG McCluskey, M Boyd, SC Ross, E Cosimo, AM Clark, WJ Angerson, ...
Clinical Cancer Research 11 (21), 7929-7937, 2005
The system can't perform the operation now. Try again later.
Articles 1–20